Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-l-carnitine
Open Access
- 1 August 2005
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (12) , 1746-1750
- https://doi.org/10.1016/j.ejca.2005.04.028
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Neurophysiological Study of Peripheral Neuropathy after High-Dose PaclitaxelClinical Cancer Research, 2004
- Neurotoxicity of taxanes: Symptoms and quality of life assessmentBreast Cancer, 2004
- Prevention of chemotherapy and radiation toxicity with glutamineCancer Treatment Reviews, 2003
- Toxicities of the platinum antineoplastic agentsExpert Opinion on Drug Safety, 2003
- Toxic neuropathy in patients with pre-existing neuropathyNeurology, 2003
- A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Dose-Finding Study of ORG 2766 in the Prevention or Delay of Cisplatin-Induced Neuropathies in Women with Ovarian CancerGynecologic Oncology, 1997
- Paclitaxel-induced neuropathyAnnals of Oncology, 1995
- Neurotoxicity of cisplatin and taxolInternational Journal of Gynecologic Cancer, 1995
- Weekly cisplatin ± glutathione in relapsed ovarian carcinomaInternational Journal of Gynecologic Cancer, 1995
- CARNITINEAnnual Review of Biochemistry, 1988